• Skip to primary navigation
  • Skip to main content
ALS Untangled®
  • How to Use
  • Mission & Methods
  • Completed Reviews
  • Future Reviews
  • Search
  • English
    • English
    • Español

Search ALS Untangled®

Patient case reports

Clenbuterol 

March 11, 2026

Clenbuterol’s effects on neuroinflammation, muscle hypertrophy, and mitochondrial activity appear potentially relevant to ALS disease pathology. Data in murine models of motor neurondisease as well as two small flawed clinical trials in PALS are also somewhat promising but due to the small sample sizes, lack of randomization or blind-ing or placebo controls, these must be […]

N-Acetylcysteine

March 4, 2026

ALSUntangled #82: N-acetylcysteine While NAC has theoretical therapeutic promise in ALS due to its antioxidant properties and ability to modulate oxidative stress and restore mitochondrial function, several case studies failed to show benefits, whether given orally or via subcutaneous injection, in slowing ALS progression or prolonging survival. Two clinical trials in PALS, including one randomized […]

ISRIB

August 7, 2025

ISR over-activation may play an important role in ALS pathogenesis, as supported by data from pre-clinical models and PALS. Several different ISR inhibitors have been tried in ALS models or inPALS with mixed results; but given the differents pecific actions of these, it is not possible to generalize across the whole class. ISRIB can attenuate […]

Alpha Lipoic Acid

May 28, 2025

ALA has several plausible mechanisms for slowing ALS progression, including enhancing energy production, reducing oxidative stress as a potent antioxidant and anti inflammation. Preclinical studies demonstrated better motor function and improved survival. One open label study suggested improved QOL and fatigue when administered as a palladium lipoic acid complex, but motor function was not assessed. […]

Light Therapy

March 12, 2021

Light therapy has not yet been convincingly shown to help people with ALS. However, at specific wavelengths and energy densities, LT appears safe and has theoretically plausible mechanisms. There is a single case report suggesting benefits for light therapy in ALS, but it contains in sufficient detail to independently confirm diagnosis or treatment benefit. Further […]

Vinpocetine

July 29, 2020

Vinpocetine has several plausible mechanisms by which it could slow ALS progression. There are two PALS online who reported improved motor functions on supplement cocktails containing Vinpocetine, but many other PALS have had nobenefits. Serious side effects from Vinpocetine are rare and it is inexpensive. We support further study of Vinpocetine in ALS, but our […]

Anti-fungals

February 26, 2020

It is unknown if fungi exist in the brain of PALS. If they do exist, it is unknown if they have any pathogenic effect, and unknown if antifungal drugs would modify ALS disease progression. There are no pre-clinical ALS model studies, verified ALS cases, or ALS clinical trials to suggest that antifungals would be of […]

Perampanel

February 20, 2019

Perampanel is a drug currently used to treat seizures which has a mechanism of action that theoretically could be useful in treating patients with ALS. A single flawed study in a mouse model of ALS showed some benefits of perampanel, but data from humans with ALS is quite limited. Due to the lack of data […]

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 5
  • Go to Next Page »

Sponsored by ALS Hope Foundation

© 2026 ALS Untangled® · All rights reserved · Website by Code the Dream & Tomatillo Design
Search ALS Untangled®